Home » Stocks » RMD

ResMed Inc. (RMD)

Stock Price: $195.24 USD 0.08 (0.04%)
Updated May 10, 2021 1:56 PM EDT - Market open
Market Cap 28.43B
Revenue (ttm) 3.09B
Net Income (ttm) 457.24M
Shares Out 145.51M
EPS (ttm) 3.13
PE Ratio 62.40
Forward PE 36.36
Dividend $1.56
Dividend Yield 0.80%
Trading Day May 10
Last Price $195.24
Previous Close $195.16
Change ($) 0.08
Change (%) 0.04%
Day's Open 196.00
Day's Range 194.35 - 196.48
Day's Volume 217,671
52-Week Range 148.29 - 223.99

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Lower device sales including weak demand for ventilators due to COVID-19 hurt ResMed's (RMD) Q3 top line.

1 week ago - Zacks Investment Research

ResMed (RMD) delivered earnings and revenue surprises of 6.56% and -2.00%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

1 week ago - Zacks Investment Research

- Year-over-year operating profit up 3%, non-GAAP operating profit up 2%

1 week ago - GlobeNewsWire

SAN DIEGO, April 27, 2021 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Brett Sandercock, chief financial officer, will present virtually at the Macquarie Australia Conference on Wedn...

1 week ago - GlobeNewsWire

Improvement in demand for Mask and Other accessories along with rapid adoption of digital health solution is likely to have contributed to ResMed's (RMD) Q3 growth.

2 weeks ago - Zacks Investment Research

ResMed (RMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 weeks ago - Zacks Investment Research

Well-known guidance from Warren Buffett can help us identify opportunities in an expensive market.

Other stocks mentioned: ALGN, VRTX
2 weeks ago - The Motley Fool

Cantel (CMD), Hill-Rom (HRC), LeMaitre (LMAT) and Masimo (MASI) can prove to be prudent investment choices in the critical care industry of the MedTech sector.

Other stocks mentioned: CMD, HRC, LMAT, MASI
1 month ago - Zacks Investment Research

Three stocks to have on your radar in the healthcare space.

Other stocks mentioned: INSP, VVOS
1 month ago - The Motley Fool

Nyxoah Reports Full Year 2020 Results

1 month ago - GlobeNewsWire

SAN DIEGO, April 08, 2021 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the third quarter of fiscal year 2021 on Thursday, Ap...

1 month ago - GlobeNewsWire

Here are some dirt-cheap MedTech value stocks - IVC, MCK, HRC - which are expected to provide long-term gains in 2021.

Other stocks mentioned: HRC, IVC, MCK, XENT
1 month ago - Zacks Investment Research

The stock of ResMed (NYSE:RMD, 30-year Financials) appears to be modestly overvalued, according to GuruFocus Value calculation. GuruFocus Value is GuruFocus' estimate of the fair value at which the stoc...

1 month ago - GuruFocus

Investors continue to be optimistic about ResMed (RMD), owing to its potential in digital health and consistent high demand for its critical care products.

1 month ago - Zacks Investment Research

There are long-term implications to the coronavirus pandemic that the market is not appreciating.

Other stocks mentioned: AAPL, ABMD, AMZN, CVX, GILD, JNJ, MDT ...
1 month ago - The Motley Fool

MedTech stocks like INMD, BASI and SMLR are expected to maintain market-beating momentum in 2021.

Other stocks mentioned: BASI, DGX, HOLX, INMD, LH, SMLR
1 month ago - Zacks Investment Research

SAN DIEGO--(BUSINESS WIRE)--ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer and Brett Sandercock, chief financial officer, will participate in a virtual f...

1 month ago - Business Wire

SAN DIEGO--(BUSINESS WIRE)---- $RMD #sleep--ResMed's 2021 U.S. Consumer Sleep Survey reveals how many Americans have symptoms of a common sleep disorder, but aren't concerned about them.

1 month ago - Business Wire

These steady, strong healthcare stocks are great picks for investors to buy and hold onto for at least the next five years. The post 7 Healthcare Stocks to Buy and Hold for the Long Term appeared first ...

Other stocks mentioned: CMPS, ILMN, JNJ, PFE, TDOC, TMO
1 month ago - InvestorPlace

ResMed (RMD) reported earnings 30 days ago. What's next for the stock?

2 months ago - Zacks Investment Research

The market itself is sitting at lofty valuations, but several S&P 500 stocks are extremely overheated. Consider giving these 10 picks a little time to cool off.

Other stocks mentioned: ABMD, CMG, FTNT, ILMN, MSCI, ROL, TER ...
2 months ago - Kiplinger

PAHC vs. RMD: Which Stock Is the Better Value Option?

Other stocks mentioned: PAHC
3 months ago - Zacks Investment Research

ResMed (RMD) reported second-quarter fiscal 2021 revenues of $800 million, up 9% from a year ago.

3 months ago - Zacks Investment Research

ResMed Inc. (RMD) CEO Mick Farrell on Q2 2021 Results - Earnings Call Transcript

3 months ago - Seeking Alpha

ResMed (RMD) delivered earnings and revenue surprises of 15.57% and 3.60%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

3 months ago - Zacks Investment Research

Shares of ResMed (NYSE:RMD) were flat in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share rose 16.53% year over year to $1.41, which beat the estimate of ...

3 months ago - Benzinga

SAN DIEGO--(BUSINESS WIRE)--ResMed Inc. (NYSE: RMD, ASX: RMD), a world-leading digital health company, today announced results for its quarter ended December 31, 2020. Second Quarter 2021 Highlights All...

3 months ago - Business Wire

On Thursday, January 28, ResMed (NYSE:RMD) will release its latest earnings report. Decipher the announcement with Benzinga's help.

3 months ago - Benzinga

Telemedicine is here to stay as the new coronavirus strain triggers a fear psychosis at large, thereby retaining solid demand for telehealth stocks.

Other stocks mentioned: AMWL, TDOC, UNH
3 months ago - Zacks Investment Research

QDEL vs. RMD: Which Stock Is the Better Value Option?

Other stocks mentioned: QDEL
3 months ago - Zacks Investment Research

SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind device to reduce the cost and complexity of dialysis, is bols...

Other stocks mentioned: OM
3 months ago - Business Wire

SAN DIEGO--(BUSINESS WIRE)--ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the second quarter of fiscal year 2021 on Thursday, January 28, 2021, a...

4 months ago - Business Wire

SAN DIEGO--(BUSINESS WIRE)--ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will present at the 39th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, ...

4 months ago - Business Wire

We have selected five MedTech growth stocks with further rooms for improvement in 2021.

Other stocks mentioned: DSRLF, HOLX, IDXX, OMI
4 months ago - Zacks Investment Research

Investors continue to be optimistic about ResMed (RMD) owing to its potential in digital health and consistent high demand for its critical care products.

4 months ago - Zacks Investment Research

A steady sales growth is key to survival for any company. Let's check Broadcom (AVGO), PennyMac Financial (PFSI), ResMed (RMD) Williams-Sonoma (WSM) & Parker-Hannifin (PH) as these are likely to witness...

Other stocks mentioned: AVGO, PFSI, PH, WSM
4 months ago - Zacks Investment Research

Here are a few stocks which are gaining from the booming digital healthcare space and are likely to maintain momentum in 2021, making them prudent investment choices.

Other stocks mentioned: NXGN, TDOC
4 months ago - Zacks Investment Research

If you're looking for a profitable portfolio of stocks that will offer the best of value and growth investing, try the growth at a reasonable price or GARP strategy.

Other stocks mentioned: LSTR, MAS, TTC
4 months ago - Zacks Investment Research

Here are a few MedTech stocks which continued to outperform their respective industries amid the pandemic and can turn out to be wise investment choices.

Other stocks mentioned: HOLX, IDXX, TMO, WST
4 months ago - Zacks Investment Research

Final Trades: Home Depot, Zimmer Holdings, Tractor Supply & more

YouTube video

The "Halftime Report" traders give their top picks to watch for the second half.

Other stocks mentioned: HD, TSCO, ZBH, UNFI
4 months ago - CNBC Television

SAN DIEGO--(BUSINESS WIRE)---- $TNDM--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced the appointment of Rajwant (Raj) Singh Sodhi ...

Other stocks mentioned: TNDM
4 months ago - Business Wire

Growth at a reasonable price or GARP strategy helps investors gain exposure to stocks that have impressive prospects and are trading at a discount.

Other stocks mentioned: APAM, LSTR, MAS
5 months ago - Zacks Investment Research

Is (RMD) Outperforming Other Medical Stocks This Year?

5 months ago - Zacks Investment Research

Investors continue to be positive about ResMed (RMD) owing to its potential in digital health and consistent high demand for its critical care products.

5 months ago - Zacks Investment Research

ResMed CEO on digital health, treating patients outside the hospital

YouTube video

ResMed CEO Michael Farrell broke down how the medical equipment benefits from the emerging digital medicine space.

5 months ago - CNBC Television

If you're looking for a profitable portfolio of stocks that will offer the best of value and growth investing, try the growth at a reasonable price or GARP strategy.

Other stocks mentioned: INTU, KLAC, MAS
5 months ago - Zacks Investment Research

Medical stocks could be making a comeback this year. The best-performing among them include medical technology companies with high Composite Ratings, a key metric measuring growth.

Other stocks mentioned: ALGN, PODD, QDEL, RGEN
5 months ago - Investors Business Daily

3 Stocks to Capitalize on Promising Medical Products Industry

Other stocks mentioned: ABT, BAX
5 months ago - Zacks Investment Research

Is (RMD) Outperforming Other Medical Stocks This Year?

6 months ago - Zacks Investment Research

Dividend growth strategy is a major source of consistent income for investors in any type of market, though it doesn't offer dramatic price appreciation.

Other stocks mentioned: ATVI, BBY, MSFT, NSP
6 months ago - Zacks Investment Research

About RMD

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep apnea, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, di... [Read more...]

Industry
Medical Instruments & Supplies
IPO Date
Jun 2, 1995
CEO
Michael Farrell
Employees
7,770
Stock Exchange
NYSE
Ticker Symbol
RMD
Full Company Profile

Financial Performance

In 2020, ResMed's revenue was $2.96 billion, an increase of 13.44% compared to the previous year's $2.61 billion. Earnings were $621.67 million, an increase of 53.65%.

Financial Statements

Analyst Forecasts

According to 10 analysts, the average rating for ResMed stock is "Hold." The 12-month stock price forecast is 211.40, which is an increase of 8.28% from the latest price.

Price Target
$211.40
(8.28% upside)
Analyst Consensus: Hold